在急性肝衰竭中的凝血病
Akash Roy1, Yogendra Kumar2, Nipun Verma2
1Institute of Gastrosciences and Liver Transplantation, Apollo Multi-speciality Hospitals, Kolkatta, India.
Best practice & research. Clinical gastroenterology
|December 21, 2024
概括
急性肝衰竭 (ALF) 涉及严重的肝功能障碍和精神状态的改变. 尽管前列血时间很高,但由于重新平衡的凝血状态,ALF的出血风险令人惊地低.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 临界护理医学 临界护理医学
背景情况:
- 急性肝衰竭 (ALF) 是一种严重的疾病,其特征是肝功能迅速失调和脑病变.
- 凝血病,通过升高的前列血时间和国际正常化比率表明,是ALF的标志.
- 传统观点将凝血病与高出血风险联系在一起.
研究的目的:
- 为了研究急性肝衰竭患者的静血平衡.
- 重新评估凝血病标志物与ALF实际出血风险之间的关联.
- 探索先进的静血试验在理解ALF病理生理学的实用性.
主要方法:
- 审查关于ALF定义和静血样本的现有文献.
- 来自粘弹性静血试验和血栓生成试验的数据分析.
- 将ALF中的静血状态与肝硬化中的静血状态进行比较.
主要成果:
- 新出现的证据表明,ALF的凝血状态重新平衡,反映了肝硬化中出现的情况.
- 尽管凝血标志物升高,但ALF中自发和手术出血的风险出乎意料地低.
- 粘弹性和血栓生成试验证实了这种重新平衡的静血特征.
结论:
- 在ALF中,静血系统不仅仅是一种促出血状态,而是复杂的再平衡系统.
- 根据这一新认识,目前对ALF凝血病的管理指南可能需要修订.
- 需要进一步的研究来优化对ALF出血风险的干预措施,考虑到重新平衡的血液静止.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
Coagulation
4.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.6K
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135


